Clinical Trial Update: Late Chronic Phase Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating treatment for late chronic phase chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED